Comparing the effect of vitamin E and Omega-3 fatty acids on metabolic syndrome

Phase 1

• Conditions: Metabolic Syndrome.; Other disorders of lipoprotein metabolism

• Registration Number: IRCT138708151434N1
• Lead Sponsor: Vice Chancellery for Research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Matching metabolic syndrome definition (based on the new definition of International Diabetes Federation (IDF) on October 2007) (The IDF consensus definition for children 10 to <16 years of age include the clustering of any three of the following risk factors: 1) obesity, waist circumference = 90% based on age and gender; 2) triglycerides = 150 mg/dL; 3) HDL- cholesterol < 40 mg/dL; 4) systolic blood pressure = 130/ diastolic blood pressure = 85 mmHg and 5) glucose = 100 mg/dL. For individuals over 16 years old, the adult definition should be applied.), undergoing at least 4 months of common therapies without significant response.
Exclusion criteria: Possible drug side effects, no compliance for follow up

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified